$KMB
KIMBERLY CLARK CORP

2023 Q2 Form 10-Q Financial Statement

#000005578523000029 Filed on April 25, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $5.134B $5.200B
YoY Change 0.67% 1.96%
Cost Of Revenue $3.403B $3.469B
YoY Change -3.71% -2.97%
Gross Profit $1.731B $1.726B
YoY Change 13.21% 13.55%
Gross Profit Margin 33.72% 33.19%
Selling, General & Admin $1.015B $924.0M
YoY Change 12.03% 4.29%
% of Gross Profit 58.64% 53.53%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $189.0M $188.0M
YoY Change -1.56% 0.0%
% of Gross Profit 10.92% 10.89%
Operating Expenses $960.0M $939.0M
YoY Change 5.73% 13.54%
Operating Profit $771.0M $787.0M
YoY Change 24.15% 13.56%
Interest Expense -$67.00M $73.00M
YoY Change -198.53% 12.31%
% of Operating Profit -8.69% 9.28%
Other Income/Expense, Net -$42.00M -$16.00M
YoY Change 55.56% 300.0%
Pretax Income $4.000M $705.0M
YoY Change -99.24% 12.62%
Income Tax -$32.00M $173.0M
% Of Pretax Income -800.0% 24.54%
Net Earnings $102.0M $566.0M
YoY Change -76.66% 8.22%
Net Earnings / Revenue 1.99% 10.88%
Basic Earnings Per Share $0.30 $1.68
Diluted Earnings Per Share $0.30 $1.67
COMMON SHARES
Basic Shares Outstanding 337.4M shares 337.5M shares
Diluted Shares Outstanding 338.9M shares 338.6M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $580.0M $524.0M
YoY Change 86.5% 6.29%
Cash & Equivalents $580.0M $524.0M
Short-Term Investments
Other Short-Term Assets $677.0M $673.0M
YoY Change 12.09% 7.0%
Inventory $2.128B $2.224B
Prepaid Expenses
Receivables $2.359B $2.430B
Other Receivables $0.00 $0.00
Total Short-Term Assets $5.744B $5.851B
YoY Change 1.45% -0.88%
LONG-TERM ASSETS
Property, Plant & Equipment $7.815B $7.866B
YoY Change -1.46% -3.06%
Goodwill $2.086B $2.090B
YoY Change -0.76% -4.0%
Intangibles
YoY Change
Long-Term Investments $299.0M $281.0M
YoY Change 10.74% 5.64%
Other Assets $1.231B $1.221B
YoY Change -1.99% -5.05%
Total Long-Term Assets $11.64B $12.33B
YoY Change -6.53% -3.47%
TOTAL ASSETS
Total Short-Term Assets $5.744B $5.851B
Total Long-Term Assets $11.64B $12.33B
Total Assets $17.38B $18.18B
YoY Change -4.04% -2.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.713B $3.788B
YoY Change 0.32% -1.51%
Accrued Expenses $2.302B $2.376B
YoY Change 10.2% 15.68%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $188.0M $536.0M
YoY Change -81.77% -44.69%
Total Short-Term Liabilities $6.598B $7.094B
YoY Change -8.48% -2.25%
LONG-TERM LIABILITIES
Long-Term Debt $8.157B $8.155B
YoY Change 2.5% -2.46%
Other Long-Term Liabilities $1.487B $810.0M
YoY Change 120.95% 13.13%
Total Long-Term Liabilities $9.644B $810.0M
YoY Change 1332.99% 13.13%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.598B $7.094B
Total Long-Term Liabilities $9.644B $810.0M
Total Liabilities $16.88B $7.904B
YoY Change 114.2% -0.87%
SHAREHOLDERS EQUITY
Retained Earnings $8.040B $8.365B
YoY Change 0.22%
Common Stock $473.0M $473.0M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $5.071B $5.153B
YoY Change -0.78%
Treasury Stock Shares
Shareholders Equity $500.0M $719.0M
YoY Change
Total Liabilities & Shareholders Equity $17.38B $18.18B
YoY Change -4.04% -2.65%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $102.0M $566.0M
YoY Change -76.66% 8.22%
Depreciation, Depletion And Amortization $189.0M $188.0M
YoY Change -1.56% 0.0%
Cash From Operating Activities $787.0M $613.0M
YoY Change 6.35% 200.49%
INVESTING ACTIVITIES
Capital Expenditures $188.0M $201.0M
YoY Change -186.64% -179.45%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities $228.0M -$4.000M
YoY Change 307.14% -500.0%
Cash From Investing Activities $40.00M -$115.0M
YoY Change -124.84% -0.86%
FINANCING ACTIVITIES
Cash Dividend Paid $391.0M
YoY Change 1.82%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00
YoY Change -100.0%
Cash From Financing Activities -755.0M -$397.0M
YoY Change 0.27% -398.5%
NET CHANGE
Cash From Operating Activities 787.0M $613.0M
Cash From Investing Activities 40.00M -$115.0M
Cash From Financing Activities -755.0M -$397.0M
Net Change In Cash 72.00M $97.00M
YoY Change -141.38% -56.5%
FREE CASH FLOW
Cash From Operating Activities $787.0M $613.0M
Capital Expenditures $188.0M $201.0M
Free Cash Flow $599.0M $412.0M
YoY Change -37.41% -9.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000055785
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-225
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
KIMBERLY-CLARK CORPORATION
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
39-0394230
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
P.O. Box 619100
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas,
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75261-9100
CY2023Q1 dei City Area Code
CityAreaCode
(972)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
281-1200
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
337381046 shares
CY2023Q1 us-gaap Revenues
Revenues
5195000000 usd
CY2022Q1 us-gaap Revenues
Revenues
5095000000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3469000000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3575000000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
1726000000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
1520000000 usd
CY2023Q1 kmb Marketing Research And General Expenses
MarketingResearchAndGeneralExpenses
924000000 usd
CY2022Q1 kmb Marketing Research And General Expenses
MarketingResearchAndGeneralExpenses
886000000 usd
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-15000000 usd
CY2022Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
59000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
787000000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
693000000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-16000000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4000000 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
7000000 usd
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
2000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
73000000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
65000000 usd
CY2023Q1 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
705000000 usd
CY2022Q1 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
626000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
173000000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
114000000 usd
CY2023Q1 kmb Income Before Equity Interest
IncomeBeforeEquityInterest
532000000 usd
CY2022Q1 kmb Income Before Equity Interest
IncomeBeforeEquityInterest
512000000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
43000000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
23000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
575000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
535000000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
9000000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
12000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
566000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
523000000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.68
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.55
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.67
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.55
CY2023Q1 us-gaap Profit Loss
ProfitLoss
575000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
535000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
93000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
53000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
8000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-11000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
-78000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
-9000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
7000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
55000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
582000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
590000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
8000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
8000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
574000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
582000000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
524000000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
427000000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2430000000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2280000000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
2224000000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
2269000000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
673000000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
753000000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
5851000000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
5729000000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7866000000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7885000000 usd
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
281000000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
238000000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
2090000000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
2074000000 usd
CY2023Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
868000000 usd
CY2022Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
851000000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1221000000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1193000000 usd
CY2023Q1 us-gaap Assets
Assets
18177000000 usd
CY2022Q4 us-gaap Assets
Assets
17970000000 usd
CY2023Q1 us-gaap Debt Current
DebtCurrent
536000000 usd
CY2022Q4 us-gaap Debt Current
DebtCurrent
844000000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3788000000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3813000000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2376000000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2289000000 usd
CY2023Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
394000000 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
388000000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
7094000000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7334000000 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
7945000000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
7578000000 usd
CY2023Q1 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
645000000 usd
CY2022Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
654000000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
612000000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
647000000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
810000000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
799000000 usd
CY2023Q1 kmb Redeemable Common And Preferred Securities Of Subsidiaries
RedeemableCommonAndPreferredSecuritiesOfSubsidiaries
210000000 usd
CY2022Q4 kmb Redeemable Common And Preferred Securities Of Subsidiaries
RedeemableCommonAndPreferredSecuritiesOfSubsidiaries
258000000 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000.0 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000.0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.25
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.25
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1200000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1200000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
378600000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
378600000 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
473000000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
473000000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
694000000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
679000000 usd
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
41200000 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
41100000 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
5153000000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
5137000000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
8365000000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
8201000000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3660000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3669000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
719000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
547000000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
142000000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
153000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
861000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
700000000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18177000000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17970000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
700000000 usd
CY2023Q1 kmb Net Income Loss Including Portion Attributableto Noncontrolling Interest Excludes Redeemable Interests Share
NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludesRedeemableInterestsShare
576000000 usd
CY2023Q1 kmb Other Comprehensive Income Loss Netof Tax Excludes Redeemable Interests Share
OtherComprehensiveIncomeLossNetofTaxExcludesRedeemableInterestsShare
5000000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6000000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
23000000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.18
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
414000000 usd
CY2023Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
-1000000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
694000000 usd
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
5153000000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
8365000000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3660000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
861000000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
737000000 usd
CY2022Q1 kmb Net Income Loss Including Portion Attributableto Noncontrolling Interest Excludes Redeemable Interests Share
NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludesRedeemableInterestsShare
535000000 usd
CY2022Q1 kmb Other Comprehensive Income Loss Netof Tax Excludes Redeemable Interests Share
OtherComprehensiveIncomeLossNetofTaxExcludesRedeemableInterestsShare
55000000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
9000000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16000000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.16
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
473000000 usd
CY2022Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
2000000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
854000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
575000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
535000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
188000000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
188000000 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
11000000 usd
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q1 us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
0 usd
CY2022Q1 us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
85000000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
24000000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
16000000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-50000000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-52000000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-2000000 usd
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-6000000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
43000000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
23000000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
85000000 usd
CY2022Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
369000000 usd
CY2023Q1 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
-6000000 usd
CY2022Q1 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
-14000000 usd
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-3000000 usd
CY2022Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
2000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
613000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
204000000 usd
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
201000000 usd
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
253000000 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
34000000 usd
CY2023Q1 kmb Investments In Time Deposits
InvestmentsInTimeDeposits
177000000 usd
CY2022Q1 kmb Investments In Time Deposits
InvestmentsInTimeDeposits
83000000 usd
CY2023Q1 kmb Maturities Of Time Deposits
MaturitiesOfTimeDeposits
259000000 usd
CY2022Q1 kmb Maturities Of Time Deposits
MaturitiesOfTimeDeposits
255000000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-4000000 usd
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-115000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-116000000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
391000000 usd
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
384000000 usd
CY2023Q1 us-gaap Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less
ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
-308000000 usd
CY2022Q1 us-gaap Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less
ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
834000000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
348000000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
300000000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
11000000 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
23000000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
30000000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
25000000 usd
CY2023Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
16000000 usd
CY2022Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
0 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-11000000 usd
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-15000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-397000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
133000000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4000000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
97000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
223000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
427000000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
270000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
524000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
493000000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
337500000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
337000000.0 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1100000 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1200000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
338600000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
338200000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
337400000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
337000000 shares
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Investment Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
-11000000 usd
CY2023Q1 us-gaap Revenues
Revenues
5195000000 usd
CY2022Q1 us-gaap Revenues
Revenues
5095000000 usd
CY2023Q1 kmb Sales Revenue Net Percent Change
SalesRevenueNetPercentChange
0.02
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
787000000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
693000000 usd
CY2023Q1 kmb Operating Income Loss Percent Change
OperatingIncomeLossPercentChange
0.14
CY2023Q1 us-gaap Revenues
Revenues
5200000000 usd
CY2022Q1 us-gaap Revenues
Revenues
5100000000 usd
CY2023Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
547000000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
572000000 usd
CY2023Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
244000000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
246000000 usd
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1355000000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1388000000 usd
CY2023Q1 us-gaap Other Inventory Supplies
OtherInventorySupplies
312000000 usd
CY2022Q4 us-gaap Other Inventory Supplies
OtherInventorySupplies
302000000 usd
CY2023Q1 us-gaap Inventory Gross
InventoryGross
2458000000 usd
CY2022Q4 us-gaap Inventory Gross
InventoryGross
2508000000 usd
CY2023Q1 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
234000000 usd
CY2022Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
239000000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
2224000000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
2269000000 usd
CY2023Q1 us-gaap Land
Land
160000000 usd
CY2022Q4 us-gaap Land
Land
156000000 usd
CY2023Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
3065000000 usd
CY2022Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
3062000000 usd
CY2023Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
14807000000 usd
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
14655000000 usd
CY2023Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
668000000 usd
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
676000000 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18700000000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18549000000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10834000000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10664000000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7866000000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7885000000 usd
CY2023Q1 us-gaap Supplier Finance Program Obligation
SupplierFinanceProgramObligation
1019000000 usd
CY2022Q4 us-gaap Supplier Finance Program Obligation
SupplierFinanceProgramObligation
998000000 usd

Files In Submission

Name View Source Status
0000055785-23-000029-index-headers.html Edgar Link pending
0000055785-23-000029-index.html Edgar Link pending
0000055785-23-000029.txt Edgar Link pending
0000055785-23-000029-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
kmb-20230331.htm Edgar Link pending
kmb-20230331.xsd Edgar Link pending
kmb-20230331_g1.jpg Edgar Link pending
kmb10qq12023exhibit31a.htm Edgar Link pending
kmb10qq12023exhibit31b.htm Edgar Link pending
kmb10qq12023exhibit32a.htm Edgar Link pending
kmb10qq12023exhibit32b.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
kmb-20230331_cal.xml Edgar Link unprocessable
kmb-20230331_def.xml Edgar Link unprocessable
kmb-20230331_lab.xml Edgar Link unprocessable
kmb-20230331_pre.xml Edgar Link unprocessable
kmb-20230331_htm.xml Edgar Link completed
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending